[KYMR] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
03-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -7.47%
YoY- -178.66%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 16,139 9,551 11,514 9,622 15,275 20,336 18,519 -8.73%
PBT -34,865 -43,002 -40,257 -36,684 -33,901 -28,582 -24,660 25.88%
Tax -818 1,916 -553 -249 51 125 98 -
NP -34,047 -43,002 -39,704 -36,435 -33,901 -28,582 -24,660 23.91%
Tax Rate - - - - - - - -
Total Cost 50,186 52,553 51,218 46,057 49,176 48,918 43,179 10.51%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -210.96 -450.24 -344.83 -378.66 -221.94 -140.55 -133.16 35.78%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.59 -0.79 -0.77 -0.71 -0.66 -0.56 -0.55 4.77%
EPS Diluted -0.59 -0.79 -0.77 -0.71 -0.66 -0.56 -0.55 4.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.